3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myelomonocytic, Chronic
5
Primary Myelofibrosis
2
Multiple Myeloma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Graft vs Host Disease
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocythemia, Essential
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Non-Malignant Neoplasm
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Motor Activity
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Prolymphocytic
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Ganglioneuroblastoma
1
Interventions
Cyclophosphamide
51
fludarabine
37
Dexamethasone
35
venetoclax
30
pembrolizumab
25
Rituximab
21
pomalidomide
18
Lenalidomide
18
Gemcitabine
17
fludarabine phosphate
15
Etoposide
14
Cytarabine
13
daratumumab
12
carfilzomib
11
Temozolomide
11
Injections
10
Cisplatin
10
Calcium Dobesilate
10
glofitamab
9
Nivolumab
9
Bortezomib
9
Azacitidine
9
selinexor
8
Vincristine
8
Immunotherapy, Adoptive
8
Carboplatin
8
obinutuzumab
7
cemiplimab
7
Drug Therapy
7
Bevacizumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Hematopoietic Stem Cell Transplantation
×
1 year
×
Clear all
No trials found.